Document Detail


Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients.
MedLine Citation:
PMID:  15741265     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of mutations at codon 804 in the RET protooncogene is disputed. Some studies have suggested that the V804L mutation causes the low penetrance multiple endocrine neoplasia type 2 syndrome, with late onset and relatively indolent course, whereas others have reported that V804L and V804M have an aggressive potential. In this paper, we report three apparently unrelated medullary thyroid carcinoma cases homozygous for these mutations. To clarify the phenotypic heterogeneity associated with these mutations, we compare the clinical data and age of diagnosis among these three homozygous patients, six other heterozygous cases from the same populations, and other homozygous and heterozygous subjects reported previously. The data are consistent with a model in which codon 804 mutations have low penetrance, the developing of medullary thyroid carcinoma being associated with a second germline or somatic mutation. The activity and (in the case of somatic mutations) timing of these other genetic alterations in the RET gene may explain the wide clinical variability associated with germline mutations at codon 804.
Authors:
F Lesueur; A Cebrian; A Cranston; J Leyland; T M Faid; M R Clements; M Robledo; J Whittaker; B A J Ponder
Related Documents :
17981785 - Genetic etiology of new forms of familial epilepsy.
23318785 - Psoriasis epidemiology: the interplay of genes and the environment.
20550555 - Screening of gabrb3 in french-canadian families with idiopathic generalized epilepsy.
10539905 - Utility of ret mutation analysis in multiple endocrine neoplasia type 2.
9698845 - Genetic variation among natural and laboratory colony populations of lutzomyia longipal...
20686305 - Epigenetic inactivation of tumor suppressor sfrp2 and point mutation in kras proto-onco...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2005-03-01
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  90     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-26     Completed Date:  2005-07-05     Revised Date:  2012-06-04    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3454-7     Citation Subset:  AIM; IM    
Affiliation:
Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amino Acid Substitution
Base Sequence
Child
Codon / genetics*
Female
Humans
Male
Middle Aged
Multiple Endocrine Neoplasia Type 2a / genetics*
Mutation, Missense*
Oncogene Proteins / genetics*
Proto-Oncogene Proteins c-ret
Receptor Protein-Tyrosine Kinases / genetics*
Thyroid Neoplasms / genetics*
Chemical
Reg. No./Substance:
0/Codon; 0/Oncogene Proteins; EC 2.7.10.1/Proto-Oncogene Proteins c-ret; EC 2.7.10.1/RET protein, human; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and i...
Next Document:  Low-fat high-fiber diet decreased serum and urine androgens in men.